Johnson & Johnson (JNJ) anticipates a $400M tariff impact by 2025 due to new trade levies, mainly slapped on MedTech goods.

Discover insights from Johnson & Johnson's Q1 2025 earnings call, highlighting 4.2% sales growth, MedTech innovation, and strategies to offset ...

The costs will be felt primarily within the company’s medical technology unit, which makes a range of medical devices and surgical products.

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Products made here might still depend on materials from overseas. And they might be made on machines needing foreign replacement parts.

Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more ...

2:11 New Brunswick family encouraged about IVF funding promise When Marissa Alexander met her best friend in Grade 3, little did she know she she would one day marry him. The 26-year-old and her ...

Johnson & Johnson has shared new, positive data from the Phase III MARIPOSA clinical trial of Rybrevant (amivantamab-vmjw) plus Lazcluze (lazertinib) in patients with locally advanced or metastatic ...

Anna Paulina Luna, R-Fla., is clashing with Speaker Mike Johnson, R-La., over her push to pass legislation that would allow lawmakers who are new parents to vote remotely. In a closed-door meeting ...

The investment will be used to improve R&D infrastructure to develop new treatments and implement new technologies to improve drug discovery and development. Johnson & Johnson has announced plans to ...